- Report
- June 2024
- 200 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- June 2024
- 200 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- June 2024
- 200 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- June 2024
- 200 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- June 2024
- 200 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- June 2024
- 152 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- March 2024
- 120 Pages
Global
From €5610EUR$6,360USD£4,928GBP
€7013EUR$7,950USD£6,161GBP
- Report
- November 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,705GBP
€2426EUR$2,750USD£2,131GBP
- Report
- November 2023
- 30 Pages
Global
From €1941EUR$2,200USD£1,705GBP
€2426EUR$2,750USD£2,131GBP
- Drug Pipelines
- February 2022
- 74 Pages
Global
From €2787EUR$3,160USD£2,449GBP
€3484EUR$3,950USD£3,061GBP
- Report
- January 2022
- 200 Pages
Global
From €5292EUR$6,000USD£4,649GBP
€6616EUR$7,500USD£5,812GBP
- Clinical Trials
- May 2021
- 60 Pages
Global
From €1058EUR$1,200USD£930GBP
€1323EUR$1,500USD£1,162GBP
- Report
- February 2024
- 111 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- February 2024
- 110 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- April 2023
- 116 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- April 2023
- 112 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- February 2024
- 175 Pages
Global
From €4410EUR$5,000USD£3,875GBP
- Report
- December 2024
- 82 Pages
Vietnam
From €3087EUR$3,500USD£2,712GBP
- Report
- July 2024
- 180 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- May 2024
- 187 Pages
Global
From €3969EUR$4,500USD£3,487GBP

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs.
Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more